Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Citation

  • Authors: Bienes-Martinez, R., Ordonez, A., Feijoo-Cuaresma, M., Corral-Escariz, M., Mateo, G., Stenina, O., Jimenez, B., Calzada, M. J.
  • Year: 2012
  • Journal: Sci Rep 2 788
  • Applications: in vitro / DNA / jetPEI
  • Cell type: RCC4
    Description: Human clear renal carcinoma cells.
    Known as:
    RCC-4.

Method

Cells were seeded and grown to 50–70% confluence, and then transfected using jetPEI. For the gagAkt or PCMV6 plasmids, 1 or 2 mg of DNA/p60 was diluted in 48 ml of 150 mM NaCl. Separately, 4 ml of jetPEI was diluted in 46 ml of 150 mM NaCl and mixed with the DNA solution. This mixture was vortexed, incubated for 20 min at room temperature, and then added to the cells.

Abstract

Thrombospondin-1 is a matricellular protein with potent antitumour activities, the levels of which determine the fate of many different tumours, including renal carcinomas. However, the factors that regulate this protein remain unclear. In renal carcinomas, hypoxic conditions enhance the expression of angiogenic factors that help adapt tumour cells to their hostile environment. Therefore, we hypothesized that anti-angiogenic factors should correspondingly be dampened. Indeed, we found that hypoxia decreased the thrombospondin-1 protein in several clear cell renal carcinoma cell lines (ccRCC), although no transcriptional regulation was observed. Furthermore, we proved that hypoxia stimulates multiple signals that independently contribute to diminish thrombospondin-1 in ccRCC, which include a decrease in the activity of oxygen-dependent prolylhydroxylases (PHDs) and activation of the PI3K/Akt signalling pathway. In addition, thrombospondin-1 regulation in hypoxia proved to be important for ccRCC cell migration and invasion.

Go to